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TO THE EDITOR
Recently, Maekawa and Inagi interestingly reported that hypoxia and endoplasmic reticulum (ER)
stress might be associated with chronic kidney disease (CKD) in the review article entitled “Stress
signal network between hypoxia and ER stress in chronic kidney disease” (Maekawa and Inagi,
2017). We would like to congratulate the authors for their elegant work and to stress the great
implication of these findings since CKD is one of the most prevalent incurable diseases worldwide
that considerably affects the patient’s life. Notwithstanding the mechanisms presented by Maekawa
and Inagi, we would like to highlight the potential contributing role of obstructive sleep apnea
(OSA) in the association found between hypoxia and ER stress with the deterioration of kidney
function.
OSA is themost prevalent sleep-disordered breathing, occurring in up to one third of the general
population (Tufik et al., 2010; Heinzer et al., 2015). It is characterized by increased upper airway
resistance and intermittent breathing pauses during sleep, leading to oxygen desaturation and sleep
fragmentation (Epstein et al., 2009). Due mainly to intermittent hypoxia-related mechanisms, OSA
has been associated with increased oxidative stress (Lavie, 2015) and inflammation (Zhang et al.,
2014), which in turnmay become potentially harmful to various tissues and organs (Anandam et al.,
2013; Salord et al., 2014).
Cumulative evidence suggests that the association between OSA and CKD is bidirectional
(Abuyassin et al., 2015). It is estimated that the prevalence of OSA in CKD is about 10 times
higher compared to the prevalence of OSA in the general population (Hanly, 2004). On the other
hand, a positive correlation between OSA severity and renal function impairment has also been
reported, demonstrating that OSA may be an important independent risk factor for initiation
and progression of CKD (Chou et al., 2011). The proposed mechanisms that relate OSA to the
deterioration of kidney function, thus leading to CKD, involve nocturnal hypoxemia and activation
of renin-angiotensin system that occurs in response to oxidative stress (Ahmed et al., 2011; Zalucky
et al., 2015).
As mentioned by Maekawa and Inagi (2017), renal hypoxia is a meaningful factor for the
development of CKD. Hypoxemia, a condition associated with OSA, represents a common and
direct pathway to the development of renal tissue hypoxia. A recent study in an animal model
of OSA using chronic intermittent hypoxia (CIH) showed that CIH accelerated renal histological
injury due to upregulation of the advanced glycation end products (RAGE) receptor and its ligand
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high mobility group box 1 (HMGB1), which are both increased
in several renal disorders. RAGE and HMGB1 activated
chronic inflammatory transduction cascades, amplifying the
inflammatory response through the recruitment of cytokines and
effector molecules, which contributes to nephron apoptosis and
accelerated renal dysfunction (Wu et al., 2016). Additionally,
OSA can disturb the homeostasis of ER through the long-
term exposure to intermittent cycles of hypoxia-reoxygenation.
Many motor neurons process large amounts of proteins that
must be properly folded within the ER, thus they are prone to
experiencing ER stress and the unfolded protein response (UPR).
Short-term intermittent hypoxia selectively activates the protein
kinase RNA-like endoplasmic reticulum kinase (PERK) pathway
of the UPR in some motor nuclei including the hypoglossal and
facial. After 8 weeks of CIH, mice presented a similar PERK
activation in both the hypoglossal and facial motor neurons,
which were associated with increased UPR (Zhu et al., 2008). The
inability of these neurons to relieve the ER stress leads to a neural
injury that is observed at the ultrastructural level (Zhu et al.,
2008). However, the role of OSA-induced hypoxia in systemic ER
stress is still unknown.
Other mechanisms that potentially relate OSA to CKD
development is the activation of the renin-angiotensin system
(Zalucky et al., 2015). This system plays an essential role in
the maintenance of renal hemodynamics, as well as in the
regulation of renal sodium transport, glomerular hemodynamics,
and glomerular filtration in both physiological and pathological
conditions (Navar, 2014). Acute hypoxia leads to stimulation
of the peripheral chemoreceptors, which increase sympathetic
outflow, thus elevating acutely the blood pressure. However,
in long-term, these repeated episodic or intermittent periods
of hypoxia activates the renin-angiotensin system (Fletcher,
2001). Evidence has shown that the nocturnal hypoxemia
influences the renal renin-angiotensin system activation, being
detrimental to negative vascular and renal outcomes (Zalucky
et al., 2015). Of note, a continuous positive airway pressure
(CPAP) intervention, which is the gold-standard treatment for
OSA, seems to improve renal hemodynamics and to down-
regulate the renal renin-angiotensin system activity (Nicholl
et al., 2014).
Finally, considering the current scenario of evidence, it is
important to understand whether ER stress plays a role in the
mechanisms by which OSA has been associated with kidney
function reduction and a higher risk of CKD so that other
therapeutic and complimentary strategies start to develop in
order to prevent kidney failure in OSA patients.
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